Pharmacokinetics of thymosin alpha1 after subcutaneous injection of three different formulations in healthy volunteers
Rost KL, Wierich W, Masayuki F, et al. International Journal of Clinical Pharmacology and Therapeutics 1999;37:51-57.
What it found
Peak blood levels were 30 to 80 µg/L. Levels did not build up with repeated daily doses, consistent with an elimination half-life of under 3 hours.
Limitations
Nine healthy Caucasian volunteers. Measures blood levels only, not effects.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.